Drug Approval | June 08, 2022
Lupin receives tentative approval from FDA for Ivacaftor tablets
Ivacaftor Tablets had estimated annual sales of USD 109 million in the US.
Ivacaftor Tablets had estimated annual sales of USD 109 million in the US.
The company has launched indigenously produced Dual Chamber Bags of global standards in India at a pocket-friendly price
The human serum-based system shows reduced interferences when testing for pyrogenicity in more complex drug products, such as in blood-derived therapeutics
Data from the three studies formed the basis of the company's application for approval by regulatory agencies
The tablets have an estimated market size of US $ 548 million for twelve months ending December 2021 according to IQVIA
Ulcerative colitis is a chronic, immune-mediated inflammatory bowel disease that can lead to substantial burden and often disability among patients
A seasoned professional, he will lead the strategy and business operations of Cadila’s branded prescriptions pharma business
This ANDA has been co-developed in partnership with Orbicular Pharmaceutical Technologies
According to the brokerage, as the pandemic has receded, the past exceptional growth in acute therapies may not be repeated (stellar double-digit growth for anti-infectives coming down)
While Pregabalin will be manufactured at the Aurangabad facility, Iloperidone will be manufactured at the Goa facility
Subscribe To Our Newsletter & Stay Updated
